đ° Full Story
Israeli Prime Minister Benjamin Netanyahu disclosed on April 24, 2026, that he received successful treatment for an early-stage malignant prostate tumour discovered during routine follow-up after surgery for benign prostate enlargement.
The 76-year-old said the lesion â described in medical reports as under one centimetre â was treated with targeted radiation therapy and follow-up imaging and blood tests showed no evidence of disease.
Netanyahuâs annual medical report, dated April 20, was released after he asked officials to delay its publication by two months to avoid giving Iran âpropagandaâ material amid the IsraelâIran war that began on Feb. 28.
Hadassah Medical Center oncologist Aharon Popovtzer and the hospital have confirmed the diagnosis and said the treatment was completed and successful.
Netanyahu said he continued working during the short treatment period and remains in âexcellent physical condition.â The announcement comes as he prepares for an upcoming White House visit and faces an October election at home while overseeing multiple regional conflicts and fragile ceasefires.
đ Based On
đ€ Social Media Insights
Social Summary
Comments add medical contextâprostate cancer is commonly indolent and often caught earlyâsupporting the view that Netanyahuâs prognosis is reassuring and likely to limit political upheaval, while noting speculative succession risks without concrete debunks.






đŹ Commentary